Key facts
- Mark S. Gelder MD has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $13,847.
- Recent insider filing activity is available below.
Reporting Owner Activity for Mark S. Gelder MD
- Location
- Redwood City, CA
- Ownership summary
-
The estimated value of Mark S. Gelder MD's disclosed insider holdings is at least $13,847 as of 14 Mar 2023.
- CHIEF MEDICAL OFFICER: Traws Pharma, Inc. (TRAW) reported at about $13.8K
Values are based on parsed SEC Forms 3/4/5 and should be verified against the source filing.
- Signature
- /s/ Mark Guerin, Attorney-in-Fact
- Source filings
- Open source filing history
Follow Filing Activity
Follow Mark S. Gelder MD and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Change
- Largest disclosed position: Onconova Therapeutics, Inc. ($13,847).
- Past-year value change for that position: .
Research use
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Reported issuer positions for Mark S. Gelder MD
TRAW
Forms 3/4/5
Onconova Therapeutics, Inc.
- Relationship
- Chief Medical Officer
- Holdings value
- $13,847
- Past year net change
- Change %
- Report period
- 13 Mar 2023
Insider Transactions Reported by Mark S. Gelder MD:
| Sym | Company | Class | Transaction | % | Reported value | Reported price | Shares | Shares after | Date | Ownership |
|---|
An asterisk next to the price means the reported price is likely invalid.